Jim Simons Medi Wound Ltd. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.35 - $9.8 $65,314 - $474,133
-48,381 Reduced 10.18%
427,041 $594,000
Q2 2022

Aug 12, 2022
BUY
$1.33 - $2.35 $23,408 - $41,360
17,600 Added 3.84%
475,422 $875,000
Q1 2022

May 13, 2022
SELL
$1.86 - $3.24 $1,488 - $2,592
-800 Reduced 0.17%
457,822 $911,000
Q4 2021

Feb 11, 2022
SELL
$2.2 - $4.01 $25,740 - $46,917
-11,700 Reduced 2.49%
458,622 $1.08 Million
Q3 2021

Nov 12, 2021
SELL
$3.34 - $4.63 $11,356 - $15,742
-3,400 Reduced 0.72%
470,322 $1.57 Million
Q2 2021

Aug 13, 2021
SELL
$3.38 - $5.71 $739,973 - $1.25 Million
-218,927 Reduced 31.61%
473,722 $1.81 Million
Q1 2021

May 13, 2021
BUY
$3.77 - $6.05 $166,735 - $267,573
44,227 Added 6.82%
692,649 $3.72 Million
Q4 2020

Feb 10, 2021
BUY
$3.12 - $4.08 $22,776 - $29,784
7,300 Added 1.14%
648,422 $2.4 Million
Q3 2020

Nov 13, 2020
SELL
$3.09 - $4.14 $118,656 - $158,976
-38,400 Reduced 5.65%
641,122 $2.41 Million
Q2 2020

Aug 13, 2020
BUY
$1.47 - $2.97 $314,941 - $636,310
214,246 Added 46.05%
679,522 $2.02 Million
Q1 2020

May 14, 2020
BUY
$1.57 - $3.1 $90,852 - $179,390
57,868 Added 14.2%
465,276 $730,000
Q4 2019

Feb 13, 2020
BUY
$2.72 - $3.15 $327,781 - $379,600
120,508 Added 42.0%
407,408 $1.26 Million
Q3 2019

Nov 13, 2019
BUY
$2.58 - $3.97 $2,580 - $3,970
1,000 Added 0.35%
286,900 $918,000
Q2 2019

Aug 12, 2019
SELL
$3.0 - $5.5 $128,400 - $235,400
-42,800 Reduced 13.02%
285,900 $966,000
Q1 2019

May 14, 2019
BUY
$4.24 - $5.24 $432,734 - $534,794
102,060 Added 45.03%
328,700 $1.64 Million
Q4 2018

Feb 13, 2019
BUY
$3.95 - $6.55 $895,228 - $1.48 Million
226,640 New
226,640 $920,000

About MediWound Ltd.

MDWD Quotes by TradingView
  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $683M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email